ENDRA Life Sciences (NDRA) Misses Q1 EPS by 3c
ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.
ENDRA Life Sciences (NASDAQ: NDRA) reported Q1 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.